Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd A Fehniger

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Haematologica|February 2, 2013
Unraveling the molecular events leading to the genesis of large granular lymphocytic leukemia reveals a new treatment strategyTodd A Fehniger
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 20, 2026
A new immunotherapy ROR: Proximal ROR1 domain targeting breast cancer via monoclonal antibodies and CAR NK cellsTodd A Fehniger
Blood|July 22, 2017
CD70 turns on NK cells to attack lymphomaTodd A Fehniger
Blood|April 6, 2013
"AbroGATAed" human NK cell developmentTodd A Fehniger
Blood|June 8, 2013
Extracellular microRNAs turn on NK cells via TLR1Todd A Fehniger
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2019
Mystery Solved: IL-15Todd A Fehniger
Nature Immunology|April 18, 2024
Fat matters for natural killer cell activityPamela Wong, Todd A Fehniger
Trends in Immunology|October 25, 2016
Harnessing NK Cell Memory for Cancer ImmunotherapyTodd A Fehniger, Megan A Cooper
Blood|February 26, 2011
Human NK cells: SET to killJeffrey W Leong, Todd A Fehniger
Trends in Immunology|May 16, 2016
Human Adaptive Natural Killer Cells: Beyond NKG2CJulia A Wagner, Todd A Fehniger
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Haematologica|February 2, 2013
Unraveling the molecular events leading to the genesis of large granular lymphocytic leukemia reveals a new treatment strategyTodd A Fehniger
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 20, 2026
A new immunotherapy ROR: Proximal ROR1 domain targeting breast cancer via monoclonal antibodies and CAR NK cellsTodd A Fehniger
Blood|July 22, 2017
CD70 turns on NK cells to attack lymphomaTodd A Fehniger
Blood|April 6, 2013
"AbroGATAed" human NK cell developmentTodd A Fehniger
Blood|June 8, 2013
Extracellular microRNAs turn on NK cells via TLR1Todd A Fehniger
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2019
Mystery Solved: IL-15Todd A Fehniger
Nature Immunology|April 18, 2024
Fat matters for natural killer cell activityPamela Wong, Todd A Fehniger
Trends in Immunology|October 25, 2016
Harnessing NK Cell Memory for Cancer ImmunotherapyTodd A Fehniger, Megan A Cooper
Blood|February 26, 2011
Human NK cells: SET to killJeffrey W Leong, Todd A Fehniger
Trends in Immunology|May 16, 2016
Human Adaptive Natural Killer Cells: Beyond NKG2CJulia A Wagner, Todd A Fehniger
Pageof 14